With a market capitalization (market cap) of $11.66B — a measure of how much the company is worth — Globus Medical, Inc. is the 879th most valuable company in Healthcare as of August 18, 2026. Shares trade at $86.44, up +1.55% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
Visit websiteAs of August 18, 2026, Globus Medical, Inc. (GMED) is worth $11.66B — this is its market capitalization, the total value of all its outstanding shares.
Globus Medical, Inc.’s market cap is $11.66B, which ranks it #879 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Globus Medical, Inc. (GMED) shares trade at $86.44, up 1.55% on the day, as of August 18, 2026.
Globus Medical, Inc. trades at a price-to-earnings (P/E) ratio of 21.7, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025